Expressions and Significance of CD80,CD86 and ICAM-1 on Acute Leukemic Cells
魏菁,黎阳,郭海霞,吴燕峰,方建培,王潇娉,周敦华,黄科,陈纯,林永潮
DOI: https://doi.org/10.3969/j.issn.1673-713x.2008.06.005
2008-01-01
Abstract:Objective To explore the variation pattern for CD80,CD86 and ICAM-1 expressions on acute leukemic cells by flow cytometry. Methods Detection of the CD80,CD86 and ICAM-1 expressions by flow cytometric analysis on the acute leukemic cells from 60 newly treated patients. There were 37 males and 23 females. The median age was 28 years old (range:2 to 85). 20 cases were acute lymphoblastic leukemia (ALL) and 40 cases acute myeloid leukemia (AML)[consisting of M1(6),M2(7),M3(7),M4(15) and M5(5)]. Results The expression of CD86 in ALL group,(32.880 ± 6.665)%,was significantly higher than that in normal control (P 0.01),CD80 expression showed no difference with normal control. The expressions of CD80 and CD86 on AML (M1,M2 and M3) cells were (0.766 ± 0.187)% and (27.210 ± 7.581)% respectively,both were significantly higher than that in normal control (P 0.01),but those on the AML (M4 and M5) cells had no difference with normal control. The expressions of ICAM-1 on AML (M1,M2 and M3) cells were (63.820 ± 7.484)% higher than that of control (P 0.01),but that was (50.590 ± 7.092)% on AML (M4 and M5) cells significantly lower than that of control (P 0.01),there is no difference of ICAM-1 expression between ALL group and normal control. Conclusions The expressions of CD80,CD86 and ICAM-1 on ALL and AML cells from newly diagnosed patients were variable. CD86 on ALL cells was high-expressing and CD80,CD86 together with ICAM-1 were high-expressing on AML (M1,M2 and M3) cells,whereas the ICAM-1 on the AML (M4 and M5) cells was low-expressing.